Serina Therapeutics (SER) Free Cash Flow (2018 - 2025)
Serina Therapeutics (SER) posted Free Cash Flow of -$6.1 million for Q4 2025, down 57.64% sequentially from -$3.8 million in Q3 2025, and down 31.8% YoY from -$8.9 million in Q4 2024.
Serina Therapeutics (SER) Free Cash Flow (2018 - 2025) Analysis & Trends
Serina Therapeutics has reported Free Cash Flow for 8 years, with the latest figure at -$6.1 million in Q4 2025.
- Quarterly Free Cash Flow fell 31.8% year-over-year to -$6.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$18.0 million (down 4.98% YoY) and the FY2025 annual result came in at -$18.0 million, down 4.98% from the prior year.
- Free Cash Flow slipped to -$6.1 million in Q4 2025 per SER's latest filing, from -$3.8 million in the prior quarter.
- Over five years, Free Cash Flow peaked at $51000.0 in Q4 2023 and troughed at -$8.0 million in Q2 2024.
- A 5-year average of -$2.6 million and a median of -$1.8 million in 2021 frame the typical range for Free Cash Flow.
- The sharpest annual moves came in 2023 and 2024: Free Cash Flow soared 103.86% in 2023, then sank 9107.84% in 2024.
- Over 5 years, Free Cash Flow stood at -$1.7 million in 2021, then rose by 23.95% to -$1.3 million in 2022, then jumped by 103.86% to $51000.0 in 2023, then tumbled by 9107.84% to -$4.6 million in 2024, then plunged by 31.8% to -$6.1 million in 2025.
- According to Business Quant data, Free Cash Flow over the past three periods registered -$6.1 million, -$3.8 million, and -$3.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.01 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 572.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -563.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 437.80 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 292.04 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 433.84 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -95.09 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 477.44 Mn |
| 10 | Serina Therapeutics | 46.70 Mn | 23.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.06 Mn |
| Dec 31, 2025 | -6.06 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Sep 30, 2025 | -3.84 Mn |
| Jun 30, 2025 | -3.80 Mn |
| Jun 30, 2025 | -3.80 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -4.59 Mn |
| Dec 31, 2024 | -4.59 Mn |
| Sep 30, 2024 | -2.97 Mn |
| Sep 30, 2024 | -2.97 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Jun 30, 2024 | -8.01 Mn |
| Mar 31, 2024 | -1.59 Mn |
| Mar 31, 2024 | -1.59 Mn |
| Dec 31, 2023 | 51,000.00 |
| Dec 31, 2023 | 51,000.00 |
| Sep 30, 2023 | -1.14 Mn |
| Sep 30, 2023 | -1.14 Mn |